Skip to main content
. Author manuscript; available in PMC: 2012 Oct 8.
Published in final edited form as: Ann Thorac Surg. 2012 Jul 12;94(4):1079–1085. doi: 10.1016/j.athoracsur.2012.05.048

Table 1.

Clinical Characteristics of Patients in Discovery and Replication Sets

Variable Discovery
N = 264
Replication
N = 264
Total
N = 528
Mean age (y) 65 66 66
Sex
 Male 141 (53%) 139 (53%) 280 (53%)
 Female 123 (47%) 125 (47%) 248 (47%)
Smoking Status
 Never smoker 54 (21%) 47 (18%) 101 (19%)
 Former smoker 142 (54%) 151 (57%) 293 (55%)
 Current/recent smoker 65 (25%) 64 (24%) 129 (24%)
Pack years (mean) 53 49 51
FEV1 ≤ 50% predicted 137 (53%) 127 (49%) 264 (51%)
DLCO ≤ 50% predicted 118 (49%) 127 (51%) 245 (50%)
Preoperative chemotherapy 37 (14%) 39 (15%) 76 (14%)
Thoracoscopic approach 45 (17%) 45 (17%) 90 (17%)
Chest wall resection 12 (5%) 17 (6%) 29 (6%)
Intraoperative transfusion 12 (5%) 11 (4%) 23 (4%)
Pathologic tumor stage
 T1 114 (43%) 115 (44%) 229 (43%)
 T2 124 (47%) 121 (46%) 245 (46%)
 T3 14 (5%) 11 (4%) 25 (43%)
 T4 8 (3%) 13 (5%) 21 (4%)
Any pulmonary complication 79 (31%) 85 (33%) 164 (31%)
Prolonged air leak 39 (15%) 43 (16%) 82 (16%)
Discharge on home oxygen 32 (12%) 29 (11%) 61 (12%)
Pneumonia 24 (9%) 26 (10%) 50 (10%)
Atelectasis requiring bronchoscopy 10 (4%) 7 (3%) 17 (4%)

There were no significant differences between the groups with respect to epidural use, preoperative radiation, tumor location, body mass index, diabetes, or other comorbidities (p > 0.05). The following pulmonary complications each occurred in less than 1.5% of patients: aspiration, acute respiratory distress syndrome, bronchopleural fistula, pulmonary embolus, and initial ventilatory support longer than 48 hours.

DLCO = diffusing capacity of lung for carbon monoxide; FEV1 = forced expiratory volume in the first second of expiration.